ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

Stryker Corporation

Stryker is a global medical technology company. It makes hip replacement implants and surgical instruments, among other products. Stryker has had to recall some of its products because of concern for patient safety. The company has paid billions of dollars to end metal-on-metal hip implant lawsuits. It has also paid nearly $100 million to the federal government to resolve criminal charges.

Stryker is a global leader in medical technology. It makes orthopedic implants and power tools for surgery, among other products.

The company has made the Fortune 500 list for 16 years. Its revenues top $12 billion.

But, Stryker has also recalled products over concerns for patient safety. Lawsuits against Stryker say some of its metal-on-metal hip implants were defective.

The company paid about $97 million to the federal government to resolve criminal charges. One of the company’s CEOs received a jail sentence.

About Stryker

Stryker has more than 40 subsidiaries. It offers products and services in over 100 countries.

The company employs about 33,000 employees globally. Its headquarters is in Kalamazoo, Michigan. Kevin A. Lobo is the current CEO.

Stryker has three business segments: Orthopaedics, MedSurg, and Neurotechnology and Spine.

Its Orthopaedics division includes knee, ankle, trauma and hip implants. It accounted for 38 percent of Stryker’s sales in 2017.

Its MedSurg unit brought in the majority of its sales at 45 percent. This unit includes its surgical and endoscopy tools.

How Much Money Does Stryker Make?

Stryker made about $12.4 billion in 2017. Its total revenue was up $3.2 billion in early 2018. The sales growth was an average of 5.6 percent above competitors’.

The company surpassed $12 billion in total revenue for the first time in 2017. Stryker says it’s had 38 consecutive years of sales growth.

Stryker spent $787 million on research and development (R&D) in 2017. The company’s lengthy list of worldwide patents reached about 6,600.

Stryker History

Dr. Homer Stryker
Dr. Homer Stryker is best known for his inventions that revolutionized orthopedic care.

Stryker got its start in 1940. Dr. Homer Stryker rented space for an orthopedics practice in Kalamazoo, Michigan’s Borgess Hospital. He used a basement room to work on ideas for medical tools.

One of his first inventions was a hospital bed called a “turning frame.” It allowed doctors to reposition patients as needed while keeping the patient immobilized.

The bed was popular with doctors and hospitals. Dr. Stryker hired his first employee to manufacture it in 1941.

In 1946, Dr. Stryker incorporated his business as the Orthopedic Frame Company. The company featured four products: the turning frame, a walking heel for casts, a surgical traction device and a cast cutter.

In 1947, Dr. Stryker developed the idea for an oscillating saw to help simplify the task of cast removal.

The saw used the motor from a malted milk mixer. The device could quickly cut through hard casts but its blade did not cut skin.

Stryker’s Legacy

In 1964, the company changed its name to Stryker Corporation.

Dr. Stryker died in 1980. The company reached $36 million in sales that same year.

Stryker Corporation went on to focus on developing new technology. It acquired other companies that could contribute to its success.

For example, it bought Pfizer’s Howmedica division in 1998 and nearly doubled its size.

Timeline of Stryker’s Notable Acquisitions
  • 1979
    Osteonics Corp – provided entry to orthopedic implant market
  • 1981
    SynOptics – provided expansion into endoscopy business
  • 1992
    Dimso SA – opened opportunities in spinal fixation field
  • 1996
    Osteo SA – provided entry into orthopedic trauma market
  • 1998
    Howmedica – sent the company’s annual sales ballooning to $1.9 billion a year
  • 2009
    Ascent Healthcare Solutions Inc. – broadened the company’s scope to include reprocessing and remanufacturing of medical devices in U.S.
  • 2011
    Boston Scientific’s Neurovascular division – expanded neurotechnology business
  • 2013
    Trauson Holdings Company Limited – expanded into value segment of emerging markets
  • 2013
    MAKO Surgical Corp – provided opportunities to further advance growth of robotic arm assisted surgery in the area of orthopedics
  • 2014
    Pivot Medical Inc., Patient Safety Technologies Inc., CoAlign Innovations Inc., Berchtold Holding AG, Small Bone Innovations Inc. – added to the company’s medical technology products
  • 2016
    Sage Products LLC and Physio-Control International Inc. – expanded medical division
  • 2018
    Entellus Medical Inc. – provided access to products designed for minimally invasive treatment of various ear, nose and throat (ENT) diseases

Stryker Products

Stryker’s Orthopaedics division makes implants. These include hip, knee, ankle and trauma implants.

The company’s operating room equipment can be found in roughly 3,000 American hospitals. It includes everything from robot-assisted surgical devices to fluid extraction devices.

stryker modular hip components
Stryker's Orthopaedics division makes components for hip replacement.

Stryker also creates surgical navigation software and communications systems. It makes hospital beds, stretchers, support surfaces and hospital furniture.

Some of Stryker’s most forward-looking innovations involve robotics and 3D printing.

Stryker has developed a proprietary 3D printing process called AMagine. The “AM” stands for “additive manufacturing,” the industry’s name for 3D printing.

Notable Stryker Products
Hip replacements
Trident, Press-Fit and Cemented Stems, Restoration Modular System
Knee replacements
X3 Advanced Bearing Technology, Triathlon, Scorpio
Computer Assisted Surgery
iNstride, eNact, eNdtrac ASM
Endoscopic Surgery Equipment
Arthroscopy, laparoscopy, gynecology, urology
Visualization and Documentation Systems
Endoscopic cameras, monitors and display systems
Surgical Navigation Systems
Navigation System II, eNlite, NavSuite
Operating Room Integration Systems
SwitchPoint Control Systems, Cable Kits, Documentation Stations
Surgical instruments (general and multi-specialty)
Surgical power tools, Cast Cutter, Cast Vac
Plating systems
VariAx Foot Locking Plate System
Hospital beds
Medical/surgical, critical care, maternity, bariatric
Hospital furniture
Overbed tables, bedside stands, seating, maternity suites
Support surfaces
XPRT, PositionPRO, Isoflex Pressure Redistribution
Neurovascular intervention
InZone Detachment System, Neuroform EZ Stent System

Stryker Lawsuits and Settlements

Stryker hip lawsuits say faulty hip implants caused severe pain and other complications that required surgery to repair. More than 3,400 people sued Stryker after problems with its Rejuvenate and ABG II hip implants led to recalls. Stryker settled lawsuits over the devices for $2 billion. But the company faces new lawsuits over its LFIT V40 hip implant. The first LFIT V40 lawsuit is scheduled for trial in 2019.

Pending Lawsuits Against Stryker

Rejuvenate and AGB II Hip Implants
Number of Lawsuits
1,240 lawsuits pending in Minnesota federal court (MDL-2441) as of May 2018
$1.43 billion to settle thousands of lawsuits in 2014; expanded in 2016 to over $2 billion
Patient Injuries
High levels of metal ions in blood and urine; bone and tissue damage; severe pain and revision surgery
LFIT V40 Femoral Head Products
Number of Lawsuits
2271 lawsuits pending in Massachusetts federal court (MDL-2768) as of May 2018; lawsuits filed in New Jersey are consolidated as multicounty litigation (MCL)
Patient Injuries
Excessive wear and metallic debris; bone and tissue damage; severe pain; revision surgery and device failure, including disassociation of femoral head from hip stem and fractured hip stem trunnion
Lawsuit Information
Lawsuits claim Stryker Tritanium Acetabular Shell hip implants were faulty and caused served pain and other serious complications that later required revision surgery.
View Lawsuits

Stryker Recalls

Stryker has recalled some of its products that led to injuries. Reasons include contamination and defects that caused bone and tissue damage. The FDA investigated these defective products.

Notable Stryker recalls

  • 2012
    Product recalled – Rejuvenate and AGB II modular hip stems

    Reason for recall – Elevated levels of the metals found in patients implanted with the devices, causing bone and tissue destruction

    Number of units recalled – More than 50,000
  • 2016
    Product recalled – LFIT Anatomic Cobalt-Chromium V40 femoral heads (LFIT V40)

    Reason for recall – Small particles of the metal were released around a component in the hip device, resulting in erosion, bone and tissue damage, and device failure (components became disassociated from each other)

    Number of units recalled – More than 42,000
  • 2016 - Sage
    Product recalled – Comfort Shield barrier cloths, incontinence clean-up cloths, M-care meatal cleansing cloths and Comfort Bath cleansing washcloths

    Reason for recall – Burkholderia cepacia contamination
  • 2017 – Sage (expanded)
    Product recalled – Oral Care products

    Reason for recall – Cross-contamination issues in Oral-care solutions causing minor irritation and allergic reactions in patients

Stryker Criminal Investigations

In 2014, Stryker subsidiary OtisMed and its former CEO pleaded guilty in federal court to intentionally distributing knee-replacement-related devices that were not FDA-approved.

OtisMed paid more than $80 million to the federal government. A court sentenced former CEO Charlie Chi to two years in prison for his role.

In 2007, Stryker agreed to pay $16.6 million to the federal government to settle a Department of Justice investigation into a former subsidiary, Physiotherapy Associates.

The settlement resolved the federal government’s claims that Physiotherapy falsely billed federally-run health care programs for services.

Stryker logo
Stryker Corporation Facts
  1. Established 1946
  2. Founder Dr. Homer Stryker
  3. Headquarters Kalamazoo, Michigan
  4. Size About 33,000 (as of May 1, 2017)
  5. 2017 Revenue $12.44 billion
  6. Subsidiaries Osteonics Corp, SynOptics, Howmedica, Ascent Healthcare Solutions Inc., Trauson Holdings Company Ltd, MAKO Surgical Corp, Patient Safety Technologies Inc., Sage Products LLC, Entellus Medical Inc., etc.

Please seek the advice of a medical professional before making health care decisions.

Kristin Compton
Written By Kristin Compton Writer

Kristin Compton's background is in legal studies. She worked as a paralegal before joining Drugwatch as a writer and researcher. She was also a member of the National Association of Legal Assistants. A mother and longtime patient, she has firsthand experience of the harmful effects prescription drugs can have on women and their children. Some of her qualifications include:

  • Bachelor of Arts in Legal Studies | Pre-Law from University of West Florida
  • Past employment with The Health Law Firm and Kerrigan, Estess, Rankin, McLeod & Thompson LLC
  • Personal experience battling severe food allergies, asthma and high-risk pregnancies
Edited By
Emily Miller
Emily Miller Managing Editor

25 Cited Research Articles writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

  1. Stryker. (n.d.). Annual Review 2017. Retrieved from
  2. Stryker. (2018, February 28). Stryker completes acquisition of Entellus Medical. Retrieved from
  3. U.S. Judicial Panel on Multidistrict Litigation. (2018, May 15). MDL Statistics Report – Distribution of Pending MDL Dockets by District. Retrieved from
  4. Stryker. (n.d.). Our Company. Retrieved from
  5. Stryker. (n.d.). Stryker Products. Retrieved from
  6. Stryker. (n.d.). Our history. Retrieved from
  7. Stryker. (n.d.). Company Overview. Retrieved from
  8. Plaintiffs’ Steering Committee MCL 296. (2017, January 25). Settlement. Retrieved from
  9. FDA. (2017, July 17). Warning Letter. Retrieved from
  10. Zacks Equity Research. (2017, August 24). Stryker Recalls Sage Unit Products, Guidance Takes a Hit. Nasdaq. Retrieved from
  11. Sage Products. (2016, April 1). Stryker completes acquisition of Sage Products, LLC. Retrieved from
  12. (2016, August 29). Class 2 Device Recall Stryker LFIT Anatomic V40 Femoral Head. Retrieved from
  13. U.S. Judicial Panel on Multidistrict Litigation. (2017, April 5). In Re: Stryker Orthopaedics LFIT V40 Femoral Head Products Liability Litigation; Transfer Order. Retrieved from
  14. New Jersey Supreme Court. (2017, May 30). Designation of New Jersey State-Court Litigation Involving Stryker LFIT CoCr V40 Femoral Heads as Multicounty Litigation. Retrieved from
  15. U.S. Dept. of Justice. (2007, September 27). Five Companies in Hip and Knee Replacement Industry Avoid Prosecution by Agreeing to Compliance Rules and Monitoring. Retrieved from
  16. U.S. Department of Justice. (2007, November 14). Stryker Corp. & Physiotherapy Associates to Pay U.S. $16.6 Million for Alleged False Claims to Federal Health Care Programs. Retrieved from
  17. Tampa Bay Business Journal. (2007, June 4). Stryker Sells Physiotherapy Associates. Retrieved from
  18. U.S. Department of Justice. (2014, December 8). Otismed Corporation And Former CEO Plead Guilty to Distributing FDA-Rejected Cutting Guides for Knee Replacement Surgeries. Retrieved from
  19. Schrag, A. (2017, February 28). 10 things to know about Stryker. Retrieved from
  20. FDA. (2015, November 19). Approval Letter; Stryker Tritanium PL Cage. Retrieved from
  21. Brune, B. (2016, May 5). With 3D Printing, Stryker Orthopaedics Moves Toward Patient-Specific Implants. Retrieved from
  22. Stryker. (n.d.). Tritanium manufacturing overview. Retrieved from
  23. Stryker. (2018, April 26). Stryker reports first quarter 2018 operating results. Retrieved from
  24. CSI (n.d.). Stryker Corp (SYK). Retrieved from
  25. Creative Commons. (n.d.). Retrieved from
View All Sources
Who Am I Calling?

Calling this number connects you with a Drugwatch representative. We will direct you to one of our trusted legal partners for a free case review.

Drugwatch's sponsors support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our sponsors page.

(888) 645-1617